| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Masataka Nakamura, Yuko Iwasaki, Toshiyuki Takahashi, Kimihiko Kaneko, Ichiro Nakashima, Takenobu Kunieda, Satoshi Kaneko, Hirofumi Kusak. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Multiple sclerosis and related disorders. vol 17. 2018-06-07. PMID:29055448. |
myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis (on) and myelitis are recognized as important differential diagnosis of aquaporin-4 (aqp4) antibody-positive neuromyelitis optica (nmo)/nmo spectrum disorder (nmosd). |
2018-06-07 |
2023-08-13 |
Not clear |
| Sasitorn Siritho, Douglas K Sato, Kimihiko Kaneko, Kazuo Fujihara, Naraporn Prayoonwiwa. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 7. 2018-01-29. PMID:26498263. |
myelin oligodendrocyte glycoprotein (anti-mog) antibody was reported in anti-aquaporin-4 (anti-aqp4) seronegative neuromyelitis optica spectrum disorders (nmosd) patients. |
2018-01-29 |
2023-08-13 |
Not clear |
| Matthias Baumann, Eva-Maria Hennes, Kathrin Schanda, Michael Karenfort, Barbara Kornek, Rainer Seidl, Katharina Diepold, Heinz Lauffer, Iris Marquardt, Jurgis Strautmanis, Steffen Syrbe, Silvia Vieker, Romana Höftberger, Markus Reindl, Kevin Rostás. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 14. 2018-01-26. PMID:26869530. |
myelin oligodendrocyte glycoprotein (mog) antibodies have been described in children with acute disseminated encephalomyelitis (adem), recurrent optic neuritis, neuromyelitis optica spectrum disorders and more recently in children with multiphasic disseminated encephalomyelitis (mdem). |
2018-01-26 |
2023-08-13 |
Not clear |
| Markus Reindl, Sven Jarius, Kevin Rostasy, Thomas Berge. Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they? Current opinion in neurology. vol 30. issue 3. 2018-01-11. PMID:28248700. |
serum igg autoantibodies against the myelin oligodendrocyte glycoprotein (mog) are present in atypical demyelinating disorders such as neuromyelitis optica spectrum disorders (nmosd) or acute disseminated encephalomyelitis. |
2018-01-11 |
2023-08-13 |
Not clear |
| Lukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J Smith, Alan S Verkma. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. Acta neuropathologica. vol 134. issue 1. 2017-12-11. PMID:28567523. |
bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. |
2017-12-11 |
2023-08-13 |
rat |
| Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W Hümmert, Corinna Trebst, Marius Ringelstein, Orhan Aktas, Alexander Winkelmann, Mathias Buttmann, Alexander Schwarz, Hanna Zimmermann, Alexander U Brandt, Diego Franciotta, Marco Capobianco, Joseph Kuchling, Jürgen Haas, Mirjam Korporal-Kuhnke, Soeren Thue Lillevang, Kai Fechner, Kathrin Schanda, Friedemann Paul, Brigitte Wildemann, Markus Reind. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Journal of neuroinflammation. vol 13. issue 1. 2017-10-10. PMID:27788675. |
antibodies to myelin oligodendrocyte glycoprotein (mog-igg) have been suggested to play a role in a subset of patients with neuromyelitis optica and related disorders. |
2017-10-10 |
2023-08-13 |
Not clear |
| Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W Hümmert, Marius Ringelstein, Corinna Trebst, Alexander Winkelmann, Alexander Schwarz, Mathias Buttmann, Hanna Zimmermann, Joseph Kuchling, Diego Franciotta, Marco Capobianco, Eberhard Siebert, Carsten Lukas, Mirjam Korporal-Kuhnke, Jürgen Haas, Kai Fechner, Alexander U Brandt, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildeman. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Journal of neuroinflammation. vol 13. issue 1. 2017-10-10. PMID:27793206. |
a subset of patients with neuromyelitis optica spectrum disorders (nmosd) has been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (mog-igg). |
2017-10-10 |
2023-08-13 |
Not clear |
| Florence Pache, Hanna Zimmermann, Janine Mikolajczak, Sophie Schumacher, Anna Lacheta, Frederike C Oertel, Judith Bellmann-Strobl, Sven Jarius, Brigitte Wildemann, Markus Reindl, Amy Waldman, Kerstin Soelberg, Nasrin Asgari, Marius Ringelstein, Orhan Aktas, Nikolai Gross, Mathias Buttmann, Thomas Ach, Klemens Ruprecht, Friedemann Paul, Alexander U Brand. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. Journal of neuroinflammation. vol 13. issue 1. 2017-10-06. PMID:27802824. |
antibodies against myelin oligodendrocyte glycoprotein (mog-igg) have been reported in patients with aquaporin-4 antibody (aqp4-igg)-negative neuromyelitis optica spectrum disorders (nmosd). |
2017-10-06 |
2023-08-13 |
Not clear |
| İpek Polat, Uluç Yiş, Pakize Karaoğlu, Muge Ayanoğlu, Tülay Öztürk, Handan Güleryüz, Semra Hız Kuru. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case. Pediatrics. vol 137. issue 5. 2017-05-31. PMID:27244783. |
myelin oligodendrocyte glycoprotein (mog) is a candidate target antigen in demyelinating central nervous system diseases, including acute disseminated encephalomyelitis (adem), neuromyelitis optica, and multiple sclerosis. |
2017-05-31 |
2023-08-13 |
human |
| Christian Lechner, Matthias Baumann, Eva-Maria Hennes, Kathrin Schanda, Klaus Marquard, Michael Karenfort, Steffen Leiz, Daniela Pohl, Sunita Venkateswaran, Martin Pritsch, Johannes Koch, Mareike Schimmel, Martin Häusler, Andrea Klein, Astrid Blaschek, Charlotte Thiels, Thomas Lücke, Ursula Gruber-Sedlmayr, Barbara Kornek, Andreas Hahn, Frank Leypoldt, Torsten Sandrieser, Helge Gallwitz, Johannes Stoffels, Christoph Korenke, Markus Reindl, Kevin Rostás. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. Journal of neurology, neurosurgery, and psychiatry. vol 87. issue 8. 2017-05-25. PMID:26645082. |
to determine the frequency and clinical-radiological associations of antibodies to myelin oligodendrocyte glycoprotein (mog) and aquaporin-4 (aqp4) in children presenting with neuromyelitis optica (nmo) and limited forms. |
2017-05-25 |
2023-08-13 |
Not clear |
| Yoshitsugu Nakamura, Hideto Nakajima, Hiroki Tani, Takafumi Hosokawa, Shimon Ishida, Fumiharu Kimura, Kimihiko Kaneko, Toshiyuki Takahashi, Ichiro Nakashim. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC neurology. vol 17. issue 1. 2017-05-16. PMID:28420330. |
anti-myelin oligodendrocyte glycoprotein (mog) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (adem), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. |
2017-05-16 |
2023-08-13 |
Not clear |
| Victoria Young, Gerardine Quaghebeu. Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders. Seminars in ultrasound, CT, and MR. vol 37. issue 5. 2017-04-10. PMID:27616312. |
the picture is more complicated with the expansion of the description to involve neuromyelitis optica spectrum disorders, new antibodies such as myelin oligodendrocyte glycoprotein and the inclusion of an antibody-negative variant. |
2017-04-10 |
2023-08-13 |
Not clear |
| Masami Tanak. The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod. Rinsho shinkeigaku = Clinical neurology. vol 56. issue 4. 2017-03-23. PMID:27010095. |
i compared the risk of developing herpes zoster between 32 ms patients treated with fingolimod (fty-ms) and 45 patients, including those with neuromyelitis optica spectrum disorder, horizontal hemianopsia without anti-aquaporin-4 antibodies, and myelitis with anti-myelin oligodendrocyte glycoprotein antibodies, treated with tacrolimus (tcr-nmo). |
2017-03-23 |
2023-08-13 |
Not clear |
| Axel Petzold, Sui Wong, Gordon T Plan. Autoimmunity in visual loss. Handbook of clinical neurology. vol 133. 2017-02-09. PMID:27112687. |
previously an enigmatic partner to multiple sclerosis, neuromyelitis optica is now established to be autoimmune and two antibodies - to aquaporin4 and to myelin oligodendrocyte glycoprotein - have been implicated in the pathogenesis. |
2017-02-09 |
2023-08-13 |
Not clear |
| Ángela Domingo-Santos, María Sepúlveda, Michele Matarazzo, Patricia Calleja-Castaño, Ana Ramos-González, Albert Saiz, Julián Benito-Leó. Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27454390. |
intravenous immunoglobulin therapy in a patient with anti-myelin oligodendrocyte glycoprotein-seropositive neuromyelitis optica. |
2017-01-23 |
2023-08-13 |
Not clear |
| Melania Spadaro, Edgar Mein. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases. Methods in molecular biology (Clifton, N.J.). vol 1304. 2016-05-05. PMID:25814289. |
autoantibodies against myelin oligodendrocyte glycoprotein (mog) occur in a proportion of patients with different inflammatory demyelinating diseases of the central nervous system, such as childhood multiple sclerosis (ms), acute disseminated encephalomyelitis (adem), and neuromyelitis optica spectrum disorders (nmosd). |
2016-05-05 |
2023-08-13 |
Not clear |
| Romana Höftberger, María Sepulveda, Thaís Armangue, Yolanda Blanco, Kevin Rostásy, Alvaro Cobo Calvo, Javier Olascoaga, Lluís Ramió-Torrentà, Markus Reindl, Julián Benito-León, Bonaventura Casanova, Georgina Arrambide, Lidia Sabater, Francesc Graus, Josep Dalmau, Albert Sai. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Multiple sclerosis (Houndmills, Basingstoke, England). vol 21. issue 7. 2016-03-29. PMID:25344373. |
we aimed to report the frequency and implications of antibodies to myelin oligodendrocyte glycoprotein (mog-ab) in adults with demyelinating syndromes suspicious for neuromyelitis optica (nmo). |
2016-03-29 |
2023-08-13 |
Not clear |
| Anne-Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, Nicolas Collongues, Jean-Baptiste Chanson, Nicholas S R Sanderson, Raija L P Lindberg, Ludwig Kappos, Jérôme de Seze, Tobias Derfus. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Journal of neuroinflammation. vol 12. 2016-03-07. PMID:25889963. |
antibodies against myelin oligodendrocyte glycoprotein (mog) have been identified in a subgroup of pediatric patients with inflammatory demyelinating disease of the central nervous system (cns) and in some patients with neuromyelitis optica spectrum disorder (nmosd). |
2016-03-07 |
2023-08-13 |
Not clear |
| Lukmanee Tradtrantip, Nithi Asavapanumas, Puay-Wah Phuan, A S Verkma. Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model. PloS one. vol 9. issue 9. 2015-12-08. PMID:25191939. |
neuromyelitis optica (nmo) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (aqp4) autoantibodies (nmo-igg) to astrocytes causes complement-dependent cytotoxicity (cdc) and inflammation resulting in oligodendrocyte and neuronal injury. |
2015-12-08 |
2023-08-13 |
human |
| Samira Saadoun, Patrick Waters, Gregory P Owens, Jeffrey L Bennett, Angela Vincent, Marios C Papadopoulo. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta neuropathologica communications. vol 2. 2014-12-08. PMID:24685353. |
antibodies against myelin oligodendrocyte glycoprotein (mog-igg) are present in some neuromyelitis optica patients who lack antibodies against aquaporin-4 (aqp4-igg). |
2014-12-08 |
2023-08-12 |
mouse |